Glenmede Trust CO Na Ionis Pharmaceuticals Inc Transaction History

Glenmede Trust CO Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$45.3 - $60.27 $9,060 - $12,054	-200 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $20,895 - $27,228	-446 Reduced 69.04%	200 $11,000
Q4 2019 Feb 12, 2020	BUY	$53.85 - $65.27 $23,694 - $28,718	440 Added 213.59%	646 $38,000
Q1 2019 May 14, 2019	SELL	$52.92 - $81.17 $793 - $1,217	-15 Reduced 6.79%	206 $16,000
Q4 2018 Feb 14, 2019	BUY	$43.37 - $59.54 $910 - $1,250	21 Added 10.5%	221 $11,000
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $9,112 - $11,914	200	200 $0

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.